Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

NCT00830024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Alprazolam Extended-Release 3 mg Tablets
DRUG: Alprazolam Extended-Release 3 mg Tablets

Sponsor

Teva Pharmaceuticals USA